$7.0m recently raised to fund Companion Animals growth initiatives and further strengthen its balance sheet

Henslow acted as the Corporate Advisor and Lead Manager to the raise which was oversubscribed and strongly supported by existing and new HNW investors. The Companion Animal range is Zamira’s new line of Australian made premium supplements for pets. Formulated by Australian vets, using ethically sourced ingredients, ZamiPet helps supports digestive and immune function, maintain vitality, joint health, cognitive function, skin, coat and nails as well as helping support the reduction of stress, tension and anxiety in dogs.

Well-positioned with a strong foundation in a growing market

Zamira is an Australian animal health brand whose mission is to improve health, wellbeing and productivity of animals across the world. They are favourably positioned as a premium brand with localised understanding and expertise – a trusted and strong Australian brand identity amongst their international competitors.

The Highlights

  • $13.9m

    Total Raised

  • 3

    Capital Raises

  • $4.6bn

    Pet Care Category (2020)

Innovation and flexibility fueled by consumer demand

Henslow has partnered with Zamira since 2019 and this is the third capital raised that we have assisted with. We look forward to continuing to support the company as they strive to become a world leader in pet health and wellbeing.


July 2023

$1.0m - Placement

Feburary 2021

$7.0m - Placement

September 2020

$3.4m - Placement

September 2019

$3.5m - Placement

Chris and the team at Henslow have facilitated a transformation of our business over the past 12-18 months; providing direction and support to simplify our capital structure, strengthen our board and attract key team members and professional investors, enabling us to pursue a growth plan that will deliver value to our shareholders.

Stewart Cairns, CEO of Zamira